India Glycols share price today

India Glycols Ltd's share price was ₹309.20 at the close on 4 November 2026. It has been rising for 26 weeks. That is 27.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹172 and ₹332, and at that close it sat 86% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today India Glycols Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 20 weeks in a row.

Over the last 11 years the share price moved +3,699% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

1. Profit up on a year earlier for 10 quarters in a row

   In the June 2026 quarter profit was ₹97 crore, +32.9% on a year earlier.

3. Highest quarterly profit in 15 quarters

   Profit of ₹97 crore in the June 2026 quarter is the highest of the last 15 quarters.

For April to June 2026 (the quarter ended 30 June 2026), India Glycols reported revenue of ₹1,130 crore, up 8.7% from ₹1,040 crore a year earlier, and a profit of ₹97.0 crore, up 32.9% from ₹73.0 crore.

India Glycols results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

India Glycols' management discussed these results on a call held on 14 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

India Glycols closed at ₹309.20 on 4 November 2026, up 45.8% from ₹212.06 a year earlier (7 November 2025) and up 237.0% over five years. Its highest weekly close since March 2016 was ₹331.95 on 16 October 2026.

India Glycols share price: then and now

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

564 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: India Glycols closed at ₹309.20, down 6.8% on the week and up 3.5% on the month. 14 Aug 2026: India Glycols held its results call for April to June 2026. Management guided: FY27 IGL Spirits operating profit above ₹500 crore.

Earlier

• Our read, 19 Jul 2026: The financial record confirms mix-led operating improvement. Debt repayment is constructive but funded by both equity and internal cash, making dilution and capital return important.
• Results for April to June 2026: Revenue up 8.7% and profit up 32.9% on a year earlier.
• 23 Mar 2026: ex-date for an interim dividend of ₹7.50 a share.
• 12 Aug 2025: Share split: face value cut from ₹10 to ₹5 a share (ex-date).

Our read of the business

The financial record confirms mix-led operating improvement. Debt repayment is constructive but funded by both equity and internal cash, making dilution and capital return important.

Latest quarter: Exit-quarter earnings held up while management focused on debt reduction and mix quality.

Our read after the latest results, written 19 July 2026.

The last was an interim dividend of ₹7.50 a share, ex-date 23 March 2026.

India Glycols dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

We do not print a yield for India Glycols: one of its dividend records from the last 12 months could not be read cleanly or matched to today’s share count, and we do not guess.

Yes. India Glycols Ltd paid out 17% of its profit as dividends in FY26, and it paid a dividend in 10 of its last 13 reported years. One of those years shows a negative figure because profit itself was negative.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 14 August 2026, India Glycols' management guided: FY27 IGL Spirits operating profit above ₹500 crore.

“We will not necessarily be suppliers to every end consumer across the world, but we will definitely be partners of choice. - Rupark Sarswat”CFO, on the call for April to June 2026

What management guided

• FY27 IGL Spirits volumes to double last year's level; Amrut's three-whisky volumes also planned to double and single-malt volume to exceed 10,000.
• FY27 IMFL contribution above 30% of potable Spirits revenue; 3-4 new brands planned toward an all-India footprint.
• Chemicals over the next 4-5 years: business approximately ₹2,500 crore and operating profit approximately ₹400 crore.
• NH Bio Pharma operating profit of ₹130-160 crore over the next 4-5 years.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 14 August 2026.

The story gets stronger if specialty growth and spirits margins prove durable while debt falls without further dilution. The story weakens if policy clarity is weak, margins normalize, specialty delivery slips or biopharma remains pressured.

Each change stops working if

• : Spirits margin contracts as premiumisation, channels or ethanol-cost advantage fade.
• : Specialty growth misses the stated ambition or commodity and import pressure overwhelms the mix benefit.
• : Debt ceases declining, fresh capital is raised on unfavorable terms, or the planned monetisation slips.

The main risks

• : Biofuel economics depend on policy progression while industry capacity has caught up with demand. ⚠ estimate
• : The financing stance changed quickly and promoter ownership declined after the equity issue. ✓ fact

Our read after the latest results, written 19 July 2026.

When India Glycols reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Demerger effectiveness date and transfer execution - check for a communicated milestone beyond the approved scheme.

India Glycols is not on any of our India lists this week.

India Glycols Ltd earned ₹97.0 Cr of net profit in the Jun 2026 quarter, +32.9% on the same quarter a year earlier. That is the 10th quarter in a row of profit growth. Full-year FY26 profit was ₹293 Cr. That is 8.6% of the quarter's revenue. The same quarter a year earlier earned ₹73.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹293 Cr (+26.8% on the year before).

Why profit moved: revenue changed +8.7% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +29.5% and revenue +12.1%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

FY26-Q4. revenue ₹976 Cr and profit ₹87 Cr as reported.

FY27-Q1. revenue ₹1,130 Cr and profit ₹97 Cr as reported.

Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.

India Glycols Ltd reported ₹1,130 Cr of revenue in the Jun 2026 quarter, +8.7% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 10 years it has grown 6.1% a year on average. The last full year, FY26, came in at ₹4,211 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹4,300 Cr.

FY26 revenue was ₹4,211 Cr, +11.8% on the year before.

Recent pace: the last four quarters grew +12.1% on average, against 6.1% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +12.0%, against +9.7% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +29.9%, against +32.0% a year (stabilising).

FY26-Q4. revenue ₹976 Cr and profit ₹87 Cr as reported.

FY27-Q1. revenue ₹1,130 Cr and profit ₹97 Cr as reported.

Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.

India Glycols Ltd's operating margin was 15.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 13 years it has been between 4.8% and 15.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +0.6 percentage points on the year while gross margin changed +2.0 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold.

FY26-Q4. revenue ₹976 Cr and profit ₹87 Cr as reported.

FY27-Q1. revenue ₹1,130 Cr and profit ₹97 Cr as reported.

Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.

Over the last 3 years, 225% of India Glycols Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹769 Cr of operating cash against ₹293 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹819 Cr of spending on assets, free cash was −₹50.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 225% of profit came in as cash: the cash cycle got 18 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner.

What to look at next: the bigger use of cash is spending on new assets, at 5.7× depreciation over three years. The next section checks what that spending is building.

India Glycols Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 47 days in FY26, down from 65 days in FY21. It spent ₹2,120 Cr on assets over the last 3 years. Customers take 30 days to pay, and stock sits for 139 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹4,211 Cr, each day of that cycle ties up about ₹11.5 Cr, so roughly ₹542 Cr is tied up in the business at any time.

FY26: customers took 30 days to pay and stock sat for 139 days, about 4.6 months of sales sitting as stock, for a full cycle of 47 days, shorter than FY21's 65.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 139 days. Customers pay about 30 days after that. Suppliers are paid at 123 days. Together that makes the 47-day cycle.

Spending on assets: ₹2,120 Cr over the last 3 years, against ₹371 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹37.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

India Glycols Ltd's P/E is 6.5×, near the high end of its own history: higher than 91% of past readings. Its usual P/E (the middle reading) is 3.4×, over 9.2 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹48.02.